Curatis Holding Ltd header image

Curatis Holding Ltd

CURN

Equity

ISIN CH1330780979 / Valor 133078097

SIX Swiss Exchange (2026-04-30)
CHF 24.40-1.61%

Curatis Holding Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Curatis Holding Ltd is a Swiss-based pharmaceutical company specializing in the acquisition, licensing, distribution, and promotion of medicines for the treatment and prevention of orphan and specialty diseases. The company holds exclusive distribution rights for over 30 different drugs within Switzerland, many of which target rare and specialized medical conditions. Curatis is actively working to expand its market presence by securing distribution rights in major European markets, including Germany, France, the UK, and Italy. In the medium to long term, the company plans to launch its own products pending regulatory approval. Curatis' growth strategy is bolstered by its aim to increase visibility and funding opportunities through potential public listing. The executive management team, including CFO Patrick Ramsauer, brings extensive experience in finance and corporate governance, further supporting the company's strategic objectives.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

142%1Y
%3Y
%5Y

Performance

78.8%1Y
101%3Y
101%5Y

Volatility

Market cap

79 M

Market cap (USD)

Daily traded volume (Shares)

2,568

Daily traded volume (Shares)

1 day high/low

13.5 / 13

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 21.88
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.60%USD 12.39
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.87%USD 70.81
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%USD 2.84
BrightSpring Health Services Inc
BrightSpring Health Services Inc BrightSpring Health Services Inc Valor: 131996976
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%USD 47.97
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%USD 4.36
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.59%USD 68.56
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.94%USD 2.15
Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.47%USD 294.73
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.38%SEK 531.00